AETHLON MEDICAL INC
Price data unavailable
Track AEMD in your trading journalAbout AETHLON MEDICAL INC
AETHLON MEDICAL INC (AEMD) is a publicly traded US company. Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
The company reports trailing twelve-month revenue of $0 and net loss of $2.02M.
Key metrics include a return on equity of -30.1%, a debt-to-equity ratio of 0.20.
Investors tracking AEMD can follow price movements, analyst estimates, and fundamental changes directly through FINOTAUR's research tools.
Fundamentals
| Revenue (TTM) | $0 |
| Net Income (TTM) | $-2.02M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -30.06% |
| Debt-to-Equity | 0.20 |
| Dividend per Share | — |
Recent News
- Benzinga·Mar 24
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
- Benzinga·Feb 25
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
- Benzinga·Feb 4
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
Want real-time analysis on AEMD?
Track it free in your trading journal. Log trades, tag setups, and review your edge.